Related Experiment Video
Updated: Jul 7, 2026

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
Published on: June 2, 2014
Headaches in a rheumatology clinic: when one pain leads to another
L Williams1, K O'Connell, N Tubridy
1Department of Neurology, St Vincent's University Hospital, Dublin, Ireland.
Insights
Chronic daily headaches (CDH) and medication overuse headaches (MOH) are common in rheumatology patients. Excessive analgesic use can create secondary chronic headache problems, requiring greater physician awareness.
Area of Science:
- Neurology
- Rheumatology
- Pharmacology
Background:
- Chronic daily headaches (CDH) affect 3-4% of Western populations.
- Medication overuse headache (MOH) often develops from treating other pain conditions.
- Rheumatology patients frequently use analgesics for non-headache pain.
Purpose of the Study:
- To assess CDH prevalence in Irish rheumatology patients.
- To determine analgesic overuse frequency in this cohort.
- To investigate the incidence of MOH in rheumatology patients.
Main Methods:
- A cohort of 114 rheumatology patients was studied.
- Headache frequency and analgesic use were recorded.
- International Classification of Headache Disorders criteria were applied.
Main Results:
- 32% of patients reported regular headaches; 12% met CDH criteria.
- 11 of 14 CDH patients also met MOH criteria.
- 70% overused medication, but only 9% met MOH criteria.
Conclusions:
- Headaches, including CDH and MOH, are prevalent in rheumatology patients.
- Physicians should be aware of analgesic overuse risks.
- Increased awareness can prevent secondary chronic headache development.
Abstract:
Chronic daily headaches (CDH) affect between 3 and 4% of the Western population and is one of the most common problems seen in the neurology clinic. It is often difficult to delineate where CDH began and medication overuse headache (MOH) supervenes. The current study analyses the development of MOH in people taking regular analgesia for reasons other than headache, namely patients attending rheumatology clinics. The aim of this study was to assess, for the first time in an Irish population of patients, whether CDH was more common in such patients as previously reported. We also wanted to see how often rheumatology patients were taking non-prescribed analgesics. The results show that, in a cohort of 114 rheumatology patients, 32% reported that they suffer from headaches regularly. Of these, 38% fulfilled criteria for CDH (or 12% of the whole cohort). Of the 14 patients with CDH, 11 also fulfilled the International Classification of Headache Disorders criteria for MOH. Seventy per cent of the patients fell under the category of medication overuse (>15 days a month for > 3 months) but only 9% fulfil criteria for MOH. Contrary to the previous work in this area, we found a very low (< 2 %) incidence of previous migraine in our patients with CDH. We conclude that headaches (both CDH and MOH) are common in this patient population. We suggest that here should be greater awareness amongst all doctors caring for these patients of the potential for creating a second chronic problem when using excessive analgesia to treat the first.
Related Concept Videos
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Analgesia and Pain Management
Rheumatic Heart Disease I: Introduction
Pain
Rheumatic Heart Disease III: Medical Management
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...

